Nanotherapeutics

Kumar, Ashutosh; Roy, Sharmili; Srivastava, Ananya; Naikwade, Mastan Mukram; Purohit, Buddhadev; Mahato, Kuldeep; Naidu, V.G.M.; Chandra, Pranjal

doi:10.1016/b978-0-12-818823-1.00010-7

Cited by 27 publications

(13 citation statements)

References 90 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 94 Currently, many new biosensors and nanomaterials-based techniques are being developed for the detection of infectious diseases particularly useful in the current scenario. 95 , 96 , 97 In the following sections, a brief overview of the three classical techniques listed above is presented.…”

Section: Overview Of Sars-cov-2 Virusmentioning

confidence: 99%

Updated insight into COVID-19 disease and health management to combat the pandemic

Roy

Ramadoss²

2021

Environmental and Health Management of Novel Coronavirus Disease (COVID-19 )

Self Cite

View full text Add to dashboard Cite

Section: Overview Of Sars-cov-2 Virusmentioning

confidence: 99%

Updated insight into COVID-19 disease and health management to combat the pandemic

Roy

Ramadoss²

2021

Environmental and Health Management of Novel Coronavirus Disease (COVID-19 )

Self Cite

View full text Add to dashboard Cite

“…Scientists from all over the world are focusing on the exceptional atomic and molecular properties of engineered nanomaterials and their composites for better biological/diagnostic applications [ [16] , [17] , [18] , [19] ]. Engineered nanomaterials integrated with functional nanoscale material can provide a new aspect towards the development of POC based modern immunosensors and other diagnostics platforms [ 20 , 21 ]). Recently, along with the development of nanostructured materials, a range of nanomaterials with diverse sizes and shapes have been utilized as the substrates for biorecognition element (BREs) immobilization [ [22] , [23] , [24] ].…”

Section: The Need For Rapid Diagnosis and Point-of-care (Poc) Detectimentioning

confidence: 99%

Miniaturized label-free smartphone assisted electrochemical sensing approach for personalized COVID-19 diagnosis

Chandra

2020

Sensors International

Self Cite

View full text Add to dashboard Cite

The COVID-19, coronavirus disease is an infectious disease caused by a novel virus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). By March 2020 the novel coronavirus known to cause a pandemic has infected nearly about 119 thousand people and killed more than 4,300 around 114 countries. Apart from the current controversial opinions about the origin, spreading, and sociological impact, it is much more imperative to put a halt to this current situation. Understanding, testing, and early to rapid diagnosis may be now the only key that can contain COVID-19 by “flattening the curve”. Biosensing is the platform that allows rapid, highly sensitive, and selective detection of analytes which in turn can serve the purpose for fast and precise detection of COVID-19. In this article, based on recently reported miniaturized sensing strategies, we hereby propose a promising personalized smartphone assisted electrochemical sensing platform for diagnosis of COVID-19.

show abstract

“…To overcome these limits, nanosized drug delivery systems are now developed. Nanotherapy, which involves the use of artificial nanoparticles loaded with low molecular weight compounds, therapeutic proteins or nucleic acids, includes several delivery devices, such as liposomes, micelles, dendrimers, polymeric or magnetic nanoparticles [167]. In this perspective, some features of the EVs are ideal as a drug carrier system for cancer treatment.…”

Section: How Can Evs Be Exploited For Pharmacological Purposes?mentioning

confidence: 99%

Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment

et al. 2021

View full text Add to dashboard Cite

Extracellular vesicles (EVs) are important mediators of intercellular communication playing a pivotal role in the regulation of physiological and pathological processes, including cancer. In particular, there is significant evidence suggesting that tumor-derived EVs exert an immunosuppressive activity during cancer progression, as well as stimulate tumor cell migration, angiogenesis, invasion and metastasis. The use of EVs as a liquid biopsy is currently a fast-growing area of research in medicine, with the potential to provide a step-change in the diagnosis and treatment of cancer, allowing the prediction of both therapy response and prognosis. EVs could be useful not only as biomarkers but also as drug delivery systems, and may represent a target for anticancer therapy. In this review, we attempted to summarize the current knowledge about the techniques used for the isolation of EVs and their roles in cancer biology, as liquid biopsy biomarkers and as therapeutic tools and targets.

show abstract

Nanotherapeutics

Cited by 27 publications

References 90 publications

Updated insight into COVID-19 disease and health management to combat the pandemic

Updated insight into COVID-19 disease and health management to combat the pandemic

Miniaturized label-free smartphone assisted electrochemical sensing approach for personalized COVID-19 diagnosis

Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment

Contact Info

Product

Resources

About